menu
    • menu

    Company profile for OliPass

    NEW Drugs in Dev: 1
    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Virtual Booth

    Contact Supplier

    Lupin Manufacturing Solutions – delivering high-quality APIs & end-to-end CDMO services for faster, cost-effective drug development.

    Virtual Booth

    Contact Supplier

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-2026-02-09

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    OliPass Corporation is committed to revolutionize our views of life sciences and bring us great quality of life.OliPass is constantly working together to find ways to provide everyone around the world a happy and healthy life.Since 2006, OliPass has been committed to revolutionizing the life sciences and improving the quality of life. Our research is focused on developing a new generation of therapeutics using our novel PNA b...
    OliPass Corporation is committed to revolutionize our views of life sciences and bring us great quality of life.OliPass is constantly working together to find ways to provide everyone around the world a happy and healthy life.Since 2006, OliPass has been committed to revolutionizing the life sciences and improving the quality of life. Our research is focused on developing a new generation of therapeutics using our novel PNA based technologies. Thanks to our dedicated team and their hard work, OliPass is now a leading biotech company with OliPass PNA Platform Technology and a growing presence throughout the globe.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    OliPasskorearepublicofnew Flag
    Country
    Country
    South Korea
    Address
    Address
    Tower 20th Floor, 16-4, 16 Beon-gil, Dongbaek Jungang-ro, Giheung-gu, Yongin, ...
    Telephone
    Telephone
    +82 . 2 . 6488 . 2232
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.olipass.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Natural Product Expo West

    Natural Product Expo West

    Not Confirmed

    envelop Contact Supplier

    Natural Product Expo West

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Vanda Pharm, OliPass partner to jointly develop antisense oligonucleotide
    Vanda Pharm, OliPass partner to jointly develop antisense oligonucleotide

    01 Oct 2022

    // PHARMABIZ

    http://www.pharmabiz.com/NewsDetails.aspx?aid=153606&sid=2

    PHARMABIZ
    01 Oct 2022
    Share Share
    Vanda Pharmaceuticals, OliPass Enter ASO R&D Alliance
    Vanda Pharmaceuticals, OliPass Enter ASO R&D Alliance

    30 Sep 2022

    // CONTRACTPHARMA

    https://www.contractpharma.com/contents/view_breaking-news/2022-09-30/vanda-pharmaceuticals-olipass-enter-aso-rd-alliance/

    CONTRACTPHARMA
    30 Sep 2022
    Share Share
    OliPass Moves Forward to Second Stage of PIIa Trial for Pain Killer OLP-1002
    OliPass Moves Forward to Second Stage of PIIa Trial for Pain Killer OLP-1002

    18 Jul 2022

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/olipass-moves-forward-to-second-stage-of-phase-2a-trial-for-pain-killer-olp-1002-301587849.html

    PRNEWSWIRE
    18 Jul 2022
    Share Share
    OliPass begins dosing in Phase IIa trial of painkiller for osteoarthritis
    OliPass begins dosing in Phase IIa trial of painkiller for osteoarthritis

    22 Feb 2022

    // CLINICALTRIALSARENA

    https://www.clinicaltrialsarena.com/news/olipass-dosing-osteoarthritis-trial/

    CLINICALTRIALSARENA
    22 Feb 2022
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search